Literature DB >> 19816199

Nuclear contour irregularity and abnormal transporter protein distribution in anterior horn cells in amyotrophic lateral sclerosis.

Yoshimi Kinoshita1, Hidefumi Ito, Asao Hirano, Kengo Fujita, Reika Wate, Masataka Nakamura, Satoshi Kaneko, Satoshi Nakano, Hirofumi Kusaka.   

Abstract

The nucleocytoplasmic transport system is essential for maintaining cell viability; transport of proteins and nucleic acids between the nucleus and the cytoplasm occurs through nuclear pore complexes (NPCs). In this study, we examined the immunohistochemical distribution of the major protein components of NPCs, Nup62, Nup88, and Nup153, in spinal cords from controls and patients with sporadic or familial amyotrophic lateral sclerosis (SALS or FALS) and its mouse model. In control subjects, immunolabeling on the nuclear envelopes of anterior horn cells (AHCs) was invariably smooth and continuous, whereas in SALS and FALS patients, the AHCs predominantly showed irregular nuclear contours. Double immunofluorescence staining demonstrated that in SALS patients, importin-beta immunoreactivity was absent in the nuclei in a subset of AHCs; in these cells, Nup62 immunolabeling of nuclear membrane was invariably irregular, suggesting that there was dysfunctional nucleocytoplasmic transport in those AHCs. In the mouse model, Nup62-immunolabeled AHCs with irregular nuclear contours were predominant as early as the presymptomatic stage and the contours became progressively discontinuous along with disease development. Together, these observations suggest that dysfunctional nucleocytoplasmic transport may underlie the pathogenesis of ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816199     DOI: 10.1097/NEN.0b013e3181bc3bec

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  39 in total

1.  Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.

Authors:  Ke Zhang; J Gavin Daigle; Kathleen M Cunningham; Alyssa N Coyne; Kai Ruan; Jonathan C Grima; Kelly E Bowen; Harsh Wadhwa; Peiguo Yang; Frank Rigo; J Paul Taylor; Aaron D Gitler; Jeffrey D Rothstein; Thomas E Lloyd
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

2.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 3.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

4.  Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

Authors:  Kyoung-In Cho; Dosuk Yoon; Minzhong Yu; Neal S Peachey; Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-04-03       Impact factor: 9.261

Review 5.  Nuclear transport, oxidative stress, and neurodegeneration.

Authors:  Vivek P Patel; Charleen T Chu
Journal:  Int J Clin Exp Pathol       Date:  2011-02-28

Review 6.  Nucleoporin genes in human diseases.

Authors:  Valeria Nofrini; Danika Di Giacomo; Cristina Mecucci
Journal:  Eur J Hum Genet       Date:  2016-04-13       Impact factor: 4.246

7.  Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.

Authors:  Barry Gertz; Margaret Wong; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

8.  Calpain-Dependent Degradation of Nucleoporins Contributes to Motor Neuron Death in a Mouse Model of Chronic Excitotoxicity.

Authors:  Kaori Sugiyama; Tomomi Aida; Masatoshi Nomura; Ryoichi Takayanagi; Hanns U Zeilhofer; Kohichi Tanaka
Journal:  J Neurosci       Date:  2017-08-16       Impact factor: 6.167

9.  Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia.

Authors:  Yvonne M Searls; Rajprasad Loganathan; Irina V Smirnova; Lisa Stehno-Bittel
Journal:  Cardiovasc Diabetol       Date:  2010-02-01       Impact factor: 9.951

10.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.